Jonathan Kay to Biological Availability
This is a "connection" page, showing publications Jonathan Kay has written about Biological Availability.
Connection Strength
0.121
-
Lambert J, Wyand M, Lassen C, Shneyer L, Thomson E, Knight A, Willers J, Kay J. Bioavailability, safety and immunogenicity of biosimilar infliximab (BOW015) compared to reference infliximab. Int J Clin Pharmacol Ther. 2016 Apr; 54(4):315-22.
Score: 0.121